annual net income:
-$121.24M-$77.17M(-175.06%)Summary
- As of today (September 14, 2025), MLTX annual net profit is -$121.24 million, with the most recent change of -$77.17 million (-175.06%) on December 31, 2024.
- During the last 3 years, MLTX annual net income has fallen by -$67.60 million (-126.02%).
- MLTX annual net income is now -133429.07% below its all-time high of -$90.80 thousand, reached on December 1, 2020.
Performance
MLTX Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
-$56.05M-$15.49M(-38.20%)Summary
- As of today (September 14, 2025), MLTX quarterly net profit is -$56.05 million, with the most recent change of -$15.49 million (-38.20%) on June 30, 2025.
- Over the past year, MLTX quarterly net income has dropped by -$31.29 million (-126.39%).
- MLTX quarterly net income is now -1120920.00% below its all-time high of -$5000.00, reached on September 1, 2020.
Performance
MLTX quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$179.12M-$31.29M(-21.17%)Summary
- As of today (September 14, 2025), MLTX TTM net profit is -$179.12 million, with the most recent change of -$31.29 million (-21.17%) on June 30, 2025.
- Over the past year, MLTX TTM net income has dropped by -$120.88 million (-207.55%).
- MLTX TTM net income is now -3582302.00% below its all-time high of -$5000.00, reached on September 1, 2020.
Performance
MLTX TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
MLTX Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -175.1% | -126.4% | -207.6% |
| 3 y3 years | -126.0% | -221.8% | -232.3% |
| 5 y5 years | -10000.0% | -10000.0% | -10000.0% |
MLTX Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -175.1% | at low | -610.6% | at low | -306.4% | at low |
| 5 y | 5-year | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
MLTX Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$56.05M(+38.2%) | -$179.12M(+21.2%) |
| Mar 2025 | - | -$40.56M(-12.6%) | -$147.83M(+21.9%) |
| Dec 2024 | -$121.24M(+175.1%) | -$46.40M(+28.5%) | -$121.24M(+46.5%) |
| Sep 2024 | - | -$36.11M(+45.9%) | -$82.74M(+42.1%) |
| Jun 2024 | - | -$24.76M(+77.2%) | -$58.24M(+27.1%) |
| Mar 2024 | - | -$13.98M(+77.2%) | -$45.84M(+4.0%) |
| Dec 2023 | -$44.08M(-31.7%) | -$7.89M(-32.1%) | -$44.08M(-16.3%) |
| Sep 2023 | - | -$11.62M(-5.9%) | -$52.66M(-5.6%) |
| Jun 2023 | - | -$12.35M(+1.1%) | -$55.78M(-8.3%) |
| Mar 2023 | - | -$12.22M(-25.8%) | -$60.84M(-5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$64.51M(+20.2%) | -$16.47M(+11.7%) | -$64.51M(+3.4%) |
| Sep 2022 | - | -$14.74M(-15.4%) | -$62.36M(+15.7%) |
| Jun 2022 | - | -$17.42M(+9.7%) | -$53.90M(-22.1%) |
| Mar 2022 | - | -$15.88M(+10.9%) | -$69.17M(+29.6%) |
| Dec 2021 | -$53.64M(>+9900.0%) | -$14.32M(+127.7%) | -$53.37M(+36.4%) |
| Sep 2021 | - | -$6.29M(-80.8%) | -$39.14M(+19.1%) |
| Jun 2021 | - | -$32.69M(>+9900.0%) | -$32.85M(>+9900.0%) |
| Mar 2021 | - | -$76.30K(-11.1%) | -$167.10K(+84.0%) |
| Dec 2020 | -$90.80K | -$85.80K(+1616.0%) | -$90.80K(+1716.0%) |
| Sep 2020 | - | -$5000.00 | -$5000.00 |
FAQ
- What is MoonLake Immunotherapeutics annual net profit?
- What is the all time high annual net income for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual net income year-on-year change?
- What is MoonLake Immunotherapeutics quarterly net profit?
- What is the all time high quarterly net income for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly net income year-on-year change?
- What is MoonLake Immunotherapeutics TTM net profit?
- What is the all time high TTM net income for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM net income year-on-year change?
What is MoonLake Immunotherapeutics annual net profit?
The current annual net income of MLTX is -$121.24M
What is the all time high annual net income for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual net profit is -$90.80K
What is MoonLake Immunotherapeutics annual net income year-on-year change?
Over the past year, MLTX annual net profit has changed by -$77.17M (-175.06%)
What is MoonLake Immunotherapeutics quarterly net profit?
The current quarterly net income of MLTX is -$56.05M
What is the all time high quarterly net income for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly net profit is -$5000.00
What is MoonLake Immunotherapeutics quarterly net income year-on-year change?
Over the past year, MLTX quarterly net profit has changed by -$31.29M (-126.39%)
What is MoonLake Immunotherapeutics TTM net profit?
The current TTM net income of MLTX is -$179.12M
What is the all time high TTM net income for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM net profit is -$5000.00
What is MoonLake Immunotherapeutics TTM net income year-on-year change?
Over the past year, MLTX TTM net profit has changed by -$120.88M (-207.55%)